Literature DB >> 19279158

Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome.

W S Layman1, D P McEwen, L A Beyer, S R Lalani, S D Fernbach, E Oh, A Swaroop, C C Hegg, Y Raphael, J R Martens, D M Martin.   

Abstract

Mutations in CHD7, a chromodomain gene, are present in a majority of individuals with CHARGE syndrome, a multiple anomaly disorder characterized by ocular Coloboma, Heart defects, Atresia of the choanae, Retarded growth and development, Genital hypoplasia and Ear anomalies. The clinical features of CHARGE syndrome are highly variable and incompletely penetrant. Olfactory dysfunction is a common feature in CHARGE syndrome and has been potentially linked to primary olfactory bulb defects, but no data confirming this mechanistic link have been reported. On the basis of these observations, we hypothesized that loss of Chd7 disrupts mammalian olfactory tissue development and function. We found severe defects in olfaction in individuals with CHD7 mutations and CHARGE, and loss of odor evoked electro-olfactogram responses in Chd7 deficient mice, suggesting reduced olfaction is due to a dysfunctional olfactory epithelium. Chd7 expression was high in basal olfactory epithelial neural stem cells and down-regulated in mature olfactory sensory neurons. We observed smaller olfactory bulbs, reduced olfactory sensory neurons, and disorganized epithelial ultrastructure in Chd7 mutant mice, despite apparently normal functional cilia and sustentacular cells. Significant reductions in the proliferation of neural stem cells and regeneration of olfactory sensory neurons in the mature Chd7(Gt/+) olfactory epithelium indicate critical roles for Chd7 in regulating neurogenesis. These studies provide evidence that mammalian olfactory dysfunction due to Chd7 haploinsufficiency is linked to primary defects in olfactory neural stem cell proliferation and may influence olfactory bulb development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279158      PMCID: PMC2678924          DOI: 10.1093/hmg/ddp112

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  73 in total

1.  CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene.

Authors:  M C J Jongmans; R J Admiraal; K P van der Donk; L E L M Vissers; A F Baas; L Kapusta; J M van Hagen; D Donnai; T J de Ravel; J A Veltman; A Geurts van Kessel; B B A De Vries; H G Brunner; L H Hoefsloot; C M A van Ravenswaaij
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

2.  MRI of the olfactory bulbs and sulci in human fetuses.

Authors:  Robin Azoulay; Catherine Fallet-Bianco; Catherine Garel; Sophie Grabar; Gabriel Kalifa; Catherine Adamsbaum
Journal:  Pediatr Radiol       Date:  2005-12-08

3.  Phenotypic spectrum of CHARGE syndrome with CHD7 mutations.

Authors:  Michihiko Aramaki; Toru Udaka; Rika Kosaki; Yoshio Makita; Nobuhiko Okamoto; Hiroshi Yoshihashi; Hirotaka Oki; Kenji Nanao; Nobuko Moriyama; Shozo Oku; Tomonobu Hasegawa; Takao Takahashi; Yoshimitsu Fukushima; Hiroshi Kawame; Kenjiro Kosaki
Journal:  J Pediatr       Date:  2006-03       Impact factor: 4.406

4.  Multiple mutations in mouse Chd7 provide models for CHARGE syndrome.

Authors:  Erika A Bosman; Andrew C Penn; John C Ambrose; Ross Kettleborough; Derek L Stemple; Karen P Steel
Journal:  Hum Mol Genet       Date:  2005-10-05       Impact factor: 6.150

5.  Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4.

Authors:  D R Schmidt; S L Schreiber
Journal:  Biochemistry       Date:  1999-11-02       Impact factor: 3.162

6.  Nestin-Cre mediated deletion of Pitx2 in the mouse.

Authors:  Anthony M Sclafani; Jennifer M Skidmore; Hemanth Ramaprakash; Andreas Trumpp; Philip J Gage; Donna M Martin
Journal:  Genesis       Date:  2006-07       Impact factor: 2.487

7.  Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development.

Authors:  D Sanlaville; H C Etchevers; M Gonzales; J Martinovic; M Clément-Ziza; A-L Delezoide; M-C Aubry; A Pelet; S Chemouny; C Cruaud; S Audollent; C Esculpavit; G Goudefroye; C Ozilou; C Fredouille; N Joye; N Morichon-Delvallez; Y Dumez; J Weissenbach; A Munnich; J Amiel; F Encha-Razavi; S Lyonnet; M Vekemans; T Attié-Bitach
Journal:  J Med Genet       Date:  2005-09-16       Impact factor: 6.318

8.  Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation.

Authors:  Seema R Lalani; Arsalan M Safiullah; Susan D Fernbach; Karine G Harutyunyan; Christina Thaller; Leif E Peterson; John D McPherson; Richard A Gibbs; Lisa D White; Margaret Hefner; Sandra L H Davenport; John M Graham; Carlos A Bacino; Nancy L Glass; Jeffrey A Towbin; William J Craigen; Steven R Neish; Angela E Lin; John W Belmont
Journal:  Am J Hum Genet       Date:  2005-12-29       Impact factor: 11.025

9.  Olfactory function in people with genetic risk of dementia.

Authors:  R Salerno-Kennedy; S Cusack; K D Cashman
Journal:  Ir J Med Sci       Date:  2005 Oct-Dec       Impact factor: 1.568

10.  CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development.

Authors:  G Pinto; V Abadie; R Mesnage; J Blustajn; S Cabrol; J Amiel; L Hertz-Pannier; A M Bertrand; S Lyonnet; R Rappaport; I Netchine
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

View more
  55 in total

Review 1.  Genetic variation in the epigenetic machinery and mental health.

Authors:  Chris Murgatroyd; Dietmar Spengler
Journal:  Curr Psychiatry Rep       Date:  2012-04       Impact factor: 5.285

Review 2.  Chromodomain proteins in development: lessons from CHARGE syndrome.

Authors:  W S Layman; E A Hurd; D M Martin
Journal:  Clin Genet       Date:  2010-04-08       Impact factor: 4.438

3.  CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome.

Authors:  Joseph A Micucci; Wanda S Layman; Elizabeth A Hurd; Ethan D Sperry; Sophia F Frank; Mark A Durham; Donald L Swiderski; Jennifer M Skidmore; Peter C Scacheri; Yehoash Raphael; Donna M Martin
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

4.  Prevalence of genetic testing in CHARGE syndrome.

Authors:  Timothy S Hartshorne; Kasee K Stratton; Conny M A van Ravenswaaij-Arts
Journal:  J Genet Couns       Date:  2010-09-28       Impact factor: 2.537

Review 5.  Inner ear manifestations in CHARGE: Abnormalities, treatments, animal models, and progress toward treatments in auditory and vestibular structures.

Authors:  Daniel I Choo; Kareem O Tawfik; Donna M Martin; Yehoash Raphael
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-10-30       Impact factor: 3.908

Review 6.  Chromodomain helicase DNA-binding proteins in stem cells and human developmental diseases.

Authors:  Joseph A Micucci; Ethan D Sperry; Donna M Martin
Journal:  Stem Cells Dev       Date:  2015-02-25       Impact factor: 3.272

7.  General olfactory sensitivity database (GOSdb): candidate genes and their genomic variations.

Authors:  Ifat Keydar; Edna Ben-Asher; Ester Feldmesser; Noam Nativ; Arisa Oshimoto; Diego Restrepo; Hiroaki Matsunami; Ming-Shan Chien; Jayant M Pinto; Yoav Gilad; Tsviya Olender; Doron Lancet
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

Review 8.  22q11 deletion syndrome: a role for TBX1 in pharyngeal and cardiovascular development.

Authors:  Peter J Scambler
Journal:  Pediatr Cardiol       Date:  2010-04       Impact factor: 1.655

9.  Chromatin remodeling in development and disease: focus on CHD7.

Authors:  Donna M Martin
Journal:  PLoS Genet       Date:  2010-07-15       Impact factor: 5.917

10.  CHD7 interacts with BMP R-SMADs to epigenetically regulate cardiogenesis in mice.

Authors:  Yuelong Liu; Cristina Harmelink; Yin Peng; Yunjia Chen; Qin Wang; Kai Jiao
Journal:  Hum Mol Genet       Date:  2013-11-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.